Company Filing History:
Years Active: 2017
Title: Jung Yim Yim: Innovator in Liquid Formulation of Fusion Proteins
Introduction
Jung Yim Yim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of liquid formulations for fusion proteins. His innovative work has the potential to enhance the stability and efficacy of therapeutic proteins.
Latest Patents
Jung Yim Yim holds a patent for a liquid formulation of a fusion protein comprising TNFR and Fc region. This invention relates to a liquid formulation that includes a TNFR-Fc fusion protein and a stabilizer. The stabilizer consists of amino acids such as proline and histidine, a buffer solution, and an isotonic agent containing sodium chloride (NaCl) and sucrose. The formulation provides excellent storage stability, allowing for long-term storage of TNFR-Fc fusion protein (etanercept) without the need for specific storage conditions. This economical formulation is advantageous for applications where the treatment of TNFR-Fc fusion protein is beneficial.
Career Highlights
Jung Yim Yim is associated with Ares Trading S.A., where he continues to advance his research and development efforts. His work has garnered attention for its practical applications in the pharmaceutical industry, particularly in improving the stability of therapeutic proteins.
Collaborations
Jung Yim Yim has collaborated with notable colleagues, including Jung Tae Lee and In Hyuk Kim. These partnerships have contributed to the advancement of his research and the successful development of innovative formulations.
Conclusion
Jung Yim Yim is a prominent inventor whose work in liquid formulations of fusion proteins has the potential to revolutionize therapeutic applications. His contributions to the field are significant and demonstrate the importance of innovation in biochemistry.